Signing Ceremony
Recently, Fuji Pharma Co. Ltd. (Fuji), a Japanese leading pharmaceutical company and has an affiliate in Thailand, named OLIC (Thailand)Ltd., signed the contract with Apo Plus Station (Thailand) Co., Ltd. (Apo Plus) to authorize Apo Plus to promote and manage the sales and marketing of Fuji’s products in Thai market. Apo Plus will initiate this business operation in the beginning of year 2019.
From Left : (Front Row) Mr. Eiji Takemasa (President & CEO, Fuji) and Mr. Suthas Thongprasert (President, Apo Plus)
From Left : (Back Row) Mr. Yoshikatsu Koyama, Mr. Takahiro Nozaki (Business Development Director, Fuji) and Mr. Yasutaka Abe (President, Apo Plus Japan), Mr. Shunsuke Abe
